248 related articles for article (PubMed ID: 9598889)
1. Oral manifestations in patients with Sjögren's syndrome.
Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
J Rheumatol; 1998 May; 25(5):906-10. PubMed ID: 9598889
[TBL] [Abstract][Full Text] [Related]
2. Oral candidiasis and Sjögren's syndrome.
Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
J Rheumatol; 1998 May; 25(5):911-5. PubMed ID: 9598890
[TBL] [Abstract][Full Text] [Related]
3. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
Alves MB; Motta AC; Messina WC; Migliari DA
Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
[TBL] [Abstract][Full Text] [Related]
4. Impact of Sjögren's syndrome on oral health-related quality of life in southern Chinese.
McMillan AS; Leung KC; Leung WK; Wong MC; Lau CS; Mok TM
J Oral Rehabil; 2004 Jul; 31(7):653-9. PubMed ID: 15210025
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome.
Márton K; Boros I; Varga G; Zelles T; Fejérdy P; Zeher M; Nagy G
Oral Dis; 2006 Sep; 12(5):480-6. PubMed ID: 16910919
[TBL] [Abstract][Full Text] [Related]
6. Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
Wu AJ
Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418
[TBL] [Abstract][Full Text] [Related]
7. Salivary and oral components of Sjögren's syndrome.
Daniels TE; Fox PC
Rheum Dis Clin North Am; 1992 Aug; 18(3):571-89. PubMed ID: 1496162
[TBL] [Abstract][Full Text] [Related]
8. Oral microbial flora in Sjögren's syndrome.
Almståhl A; Kroneld U; Tarkowski A; Wikström M
J Rheumatol; 1999 Jan; 26(1):110-4. PubMed ID: 9918250
[TBL] [Abstract][Full Text] [Related]
9. Oral findings in coeliac disease and Sjögren's syndrome.
Patinen P; Aine L; Collin P; Hietanen J; Korpela M; Enckell G; Kautiainen H; Konttinen YT; Reunala T
Oral Dis; 2004 Nov; 10(6):330-4. PubMed ID: 15533207
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome in dermatology.
Fox RI; Liu AY
Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
[TBL] [Abstract][Full Text] [Related]
12. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
Erlichman M
Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care.
Leung KC; McMillan AS; Cheung BP; Leung WK
Oral Dis; 2008 Mar; 14(2):163-73. PubMed ID: 18302677
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects.
Gannot G; Lancaster HE; Fox PC
J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331
[TBL] [Abstract][Full Text] [Related]
15. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
[TBL] [Abstract][Full Text] [Related]
16. Evaluation, differential diagnosis, and treatment of xerostomia.
Daniels TE
J Rheumatol Suppl; 2000 Dec; 61():6-10. PubMed ID: 11128701
[TBL] [Abstract][Full Text] [Related]
17. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
18. [Sjögren's syndrome. Consequences for oral health].
Vissink A; Spijkervet FK; Kalk WW; van Nieuw Amerongen A; Bootsma H; Kallenberg CG
Ned Tijdschr Tandheelkd; 1997 Dec; 104(12):458-62. PubMed ID: 11923921
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of Sjögren's syndrome.
Provost TT; Watson R
Rheum Dis Clin North Am; 1992 Aug; 18(3):609-16. PubMed ID: 1496164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
